These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16598276)

  • 21. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional magnetic resonance imaging and estrogen effects on the brain: cautious interpretation of a BOLD finding.
    Henderson VW; Greicius MD
    Menopause; 2010 Jul; 17(4):669-71. PubMed ID: 20944455
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 24. Update on progestogen therapy.
    Fraser IS; Lobo R
    J Reprod Med; 1999 Feb; 44(2 Suppl):139-40. PubMed ID: 11392022
    [No Abstract]   [Full Text] [Related]  

  • 25. Spray-on estrogen effective in relieving menopausal hot flashes.
    Mayo Clin Womens Healthsource; 2008 Dec; 12(12):3. PubMed ID: 18985020
    [No Abstract]   [Full Text] [Related]  

  • 26. To the editor. Post menopausal hormone therapy in clinical perspective.
    Turner RJ
    Menopause; 2008; 15(2):404. PubMed ID: 17545923
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of short- and long-term estrogen and progesterone replacement on behavioral responses and c-fos mRNA levels in female rats after acute cocaine administration.
    Niyomchai T; Jenab S; Festa ED; Akhavan A; Quiñones-Jenab V
    Brain Res; 2006 Dec; 1126(1):193-9. PubMed ID: 16962079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk.
    Allison MA; Manson JE
    Menopause; 2009; 16(4):619-20. PubMed ID: 19503007
    [No Abstract]   [Full Text] [Related]  

  • 29. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
    Studd J
    Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Hormones down under: hormone therapy use after the Women's Health Initiative.
    Dennerstein G
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):80; author reply 80. PubMed ID: 17261108
    [No Abstract]   [Full Text] [Related]  

  • 31. The heart of the WHI study: time for hormone therapy policies to be revised.
    Pines A; Sturdee DW; MacLennan AH; Schneider HP; Burger H; Fenton A
    Climacteric; 2007 Aug; 10(4):267-9. PubMed ID: 17653951
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy aggravates postmenopausal urinary incontinence.
    Prescrire Int; 2006 Aug; 15(84):137-8. PubMed ID: 16989027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical practice impact of the Women's Health Initiative: political vs biologic correctness.
    Notelovitz M
    Maturitas; 2003 Jan; 44(1):3-9. PubMed ID: 12568730
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term outcomes of vasomotor symptom treatments: what happens after we pull the plug--or the needles.
    Soares CN
    Menopause; 2010 Mar; 17(2):226-7. PubMed ID: 20142785
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of biological sex and diet on the development of heart failure.
    Konhilas JP; Leinwand LA
    Circulation; 2007 Dec; 116(23):2747-59. PubMed ID: 18056540
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogens and the brain. Preface.
    Simpson ER
    Semin Reprod Med; 2009 May; 27(3):205. PubMed ID: 19401951
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
    Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
    Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.